Brief Summary:
The main purpose of the study is to learn about how well Trumenba vaccine shot works against gonorrhea infection.
This study looks at data records from a database in the United States.
This study includes patient's data from the database who:
Are 15-30 years old.
Have received at least one dose of Trumenba and a MenACWY vaccine or who have received only MenACWY vaccine.
Have enough months of data in the database.
This data has already been collected in the past and is being studied between April and June of 2023.
Closest Location
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.
Condition
Gonorrhea, Chlamydia, Meningococcal Vaccines
Sex
Male or Female
Age
15 - 30 years